ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $243,000 | -56.5% | 0 | -100.0% | 1.87% | +7.8% |
| Q1 2017 | $559,000 | -5.9% | 21,106 | -9.3% | 1.73% | -17.6% |
| Q4 2016 | $594,000 | +75.7% | 23,272 | +148.9% | 2.10% | +149.1% |
| Q3 2016 | $338,000 | +6.3% | 9,351 | 0.0% | 0.84% | +34.0% |
| Q2 2016 | $318,000 | +28.7% | 9,351 | 0.0% | 0.63% | +33.8% |
| Q1 2016 | $247,000 | -45.8% | 9,351 | 0.0% | 0.47% | -37.9% |
| Q4 2015 | $456,000 | -27.3% | 9,351 | -62.9% | 0.76% | -38.6% |
| Q3 2015 | $627,000 | -21.3% | 25,194 | 0.0% | 1.24% | +22.4% |
| Q2 2015 | $797,000 | +23.2% | 25,194 | +48.2% | 1.01% | -16.7% |
| Q1 2015 | $647,000 | -23.2% | 16,996 | -21.3% | 1.21% | -41.9% |
| Q4 2014 | $842,000 | – | 21,603 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |